News | Charter Research

Meditation as Medicine: The Science Behind the Ancient Practice

Mounting research indicates that as many as 40 percent of dementia cases may be prevented with lifestyle modifications. In addition to...

99 views

Charter Research Tests Alzheimer’s Drug Donanemab in Phase 3 Trials

Eli Lilly’s experimental Alzheimer’s treatment donanemab has shown promise in slowing cognitive decline in people with the early symptoms...

541 views

New Study Shows the Importance of Exercise in Brain Health

Just as regular exercise can keep aging bodies in shape, a recent study showed that aerobic exercise can keep the brain in shape. Aerobic...

93 views

Resident of The Villages Fights Alzheimer’s Disease by Joining Clinical Trials

Sheldon Freedman, a former arts administrator and resident of The Villages, Florida, knew very little about Alzheimer’s disease when he...

530 views

Type 3 Diabetes – New Alzheimer’s Drug Targets Blood Sugar Regulation

Is Alzheimer’s disease essentially a third type of diabetes? The human brain requires glucose to function. In fact, glucose is your...

292 views

New Drug Made from Algae Paves the Way for a New Alzheimer's Treatment Approach

Green Valley Pharmaceutical Company, a Shanghai based biotech startup, has cleared regulatory hurdles from China's FDA-equivalent to...

714 views

Exploring New Therapies for the "Brain Fog" of COVID-19

Some people complain of mental fogginess after COVID-19. As new research and therapies emerge, what new insights can we learn about the...

114 views

Can a Blood Test Help to Diagnose Alzheimer’s?

Soon, Alzheimer’s diagnosis may be worlds easier. We speak with experts on the new wave of diagnostic blood tests, including experts from...

558 views

Exploring a Possible Alzheimer’s Cure With Immunotherapy

An increasing number of scientists and drug developers are turning to immunotherapy – an experimental cancer cure – in the quest for a...

98 views